| Literature DB >> 27883048 |
Yunhe Zhao1, Kaidi Cui1, Chunmei Xu1, Qiuhong Wang1, Yao Wang1, Zhengqun Zhang2, Feng Liu1, Wei Mu1.
Abstract
Benzothiazole, a microbial secondary metabolite, has been demonstrated to possess fumigant activity against Sclerotinia sclerotiorum, Ditylenchus destructor and Bradysia odoriphaga. However, to facilitate the development of novel microbial pesticides, the mode of action of benzothiazole needs to be elucidated. Here, we employed iTRAQ-based quantitative proteomics analysis to investigate the effects of benzothiazole on the proteomic expression of B. odoriphaga. In response to benzothiazole, 92 of 863 identified proteins in B. odoriphaga exhibited altered levels of expression, among which 14 proteins were related to the action mechanism of benzothiazole, 11 proteins were involved in stress responses, and 67 proteins were associated with the adaptation of B. odoriphaga to benzothiazole. Further bioinformatics analysis indicated that the reduction in energy metabolism, inhibition of the detoxification process and interference with DNA and RNA synthesis were potentially associated with the mode of action of benzothiazole. The myosin heavy chain, succinyl-CoA synthetase and Ca+-transporting ATPase proteins may be related to the stress response. Increased expression of proteins involved in carbohydrate metabolism, energy production and conversion pathways was responsible for the adaptive response of B. odoriphaga. The results of this study provide novel insight into the molecular mechanisms of benzothiazole at a large-scale translation level and will facilitate the elucidation of the mechanism of action of benzothiazole.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27883048 PMCID: PMC5121901 DOI: 10.1038/srep37730
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The motility and ingestion of B. odoriphaga after treatment with distilled water for 0 h (A), 6 h (B) and 24 h (C) and with the LC30 of benzothiazole for 0 h (D), 6 h (E) and 24 h (F).
Figure 2Experimental design and schematic diagram of the workflow of this study.
CON: control, BT: benzothiazole.
Figure 3(A) Spectra, peptides and proteins identified from iTRAQ proteomics by searching against the Nematocera database. (B) Molecular weight distribution of the proteins that were identified from the iTRAQ analysis of B. odoriphaga.
Differentially expressed proteins identified by the iTRAQ analysis of B. odoriphaga that are related to the action mechanism of benzothiazole.
| No. | Accession ID | Description | Unique Peptide | Score | Coverage (%) | Fold change (Mean ± SD) |
|---|---|---|---|---|---|---|
| 1 | gi|563354894 | triose-phosphate isomerase [ | 1 | 305 | 11.3 | 0.726 ± 0.368 |
| 2 | gi|167862461 | actin-2 [ | 1 | 5218 | 38.8 | 1.201 ± 0.216 |
| 3 | gi|197260680 | calponin/transgelin [ | 1 | 289 | 7.4 | 1.152 ± 0.119 |
| 4 | gi|157113604 | vacuolar ATP synthase subunit H [ | 1 | 140 | 7.4 | 0.765 ± 0.252 |
| 5 | gi|545920623 | putative transporter abc superfamily [ | 2 | 47 | 2.1 | 0.853 ± 0.117 |
| 6 | gi|157110428 | developmentally regulated GTP-binding protein 1 [ | 2 | 117 | 6.3 | 0.694 ± 0.017 |
| 7 | gi|157127037 | superoxide dismutase [ | 1 | 94 | 6.5 | 0.807 ± 0.002 |
| 8 | gi|545918281 | putative peroxisomal 3-ketoacyl-CoA thiolase [ | 3 | 183 | 4.4 | 0.869 ± 0.103 |
| 9 | gi|157103945 | dihydropyrimidine dehydrogenase [ | 1 | 92 | 1.2 | 0.860 ± 0.046 |
| 10 | gi|94468478 | nucleoside diphosphate kinase [ | 1 | 99 | 17.3 | 0.786 ± 0.020 |
| 11 | gi|157131967 | prohibitin [ | 5 | 350 | 14.1 | 0.906 ± 0.128 |
| 12 | gi|94468404 | 40 S ribosomal protein S4 [ | 1 | 140 | 7.3 | 0.826 ± 0.030 |
| 13 | gi|545917000 | putative oligosaccharyltransferase gamma subunit [ | 2 | 124 | 7.3 | 0.895 ± 0.100 |
| 14 | gi|157361547 | 40 S ribosomal S30 protein-like protein [ | 2 | 249 | 8.5 | 0.830 ± 0.035 |
aMascot score.
bSequence coverage.
cMean fold-change was calculated from two biological replicates (the same is true in in Tables 2 and 3).
dBT/CON: Benzothiazole VS Control.
Differentially expressed proteins identified by the iTRAQ analysis of B. odoriphaga that are related to the stress response to benzothiazole.
| No. | Accession ID | Description | Unique Peptide | Score | Coverage (%) | Fold change (Mean ± SD) BT/CON | |
|---|---|---|---|---|---|---|---|
| 6 h | 24 h | ||||||
| 15 | gi|167881575 | myosin heavy chain [ | 2 | 6019 | 18.3 | 1.291 ± 0.062 | 1.825 ± 0.261 |
| 16 | gi|563354922 | succinyl-CoA synthetase alpha [ | 6 | 441 | 23.6 | 0.864 ± 0.180 | 1.439 ± 0.042 |
| 17 | gi|524935491 | putative polyadenylate-binding protein rrm superfamily [ | 2 | 159 | 8.8 | 1.372 ± 0.107 | 3.031 ± 0.029 |
| 18 | gi|158295513 | Calcium-transporting ATPase sarcoplasmic [ | 2 | 2062 | 16 | 1.314 ± 0.035 | 3.379 ± 0.291 |
| 19 | gi|167880127 | 26 S protease regulatory subunit 6 A [ | 5 | 239 | 18.2 | 0.698 ± 0.183 | 1.261 ± 0.010 |
| 20 | gi|167875398 | mitochondrial chaperone BCS1 [ | 1 | 191 | 2.8 | 1.173 ± 0.115 | 0.559 ± 0.000 |
| 21 | gi|34867976 | N-ethylmaleimide-sensitive factor [ | 3 | 93 | 4.9 | 0.807 ± 0.141 | 0.685 ± 0.025 |
| 22 | gi|338841083 | cytochrome P450 9J28, partial [ | 1 | 55 | 2.1 | 0.830 ± 0.017 | 0.730 ± 0.092 |
| 23 | gi|545921305 | putative S3aE ribosomal protein [ | 2 | 105 | 10.1 | 1.292 ± 0.144 | 2.662 ± 0.804 |
| 24 | gi|524935628 | putative elongation factor 1-beta2 [ | 1 | 276 | 4 | 1.137 ± 0.103 | 1.968 ± 0.025 |
| 25 | gi|157135572 | profilin [ | 2 | 178 | 15.9 | 1.140 ± 0.181 | 2.278 ± 0.827 |
Differentially expressed proteins identified by the iTRAQ analysis of B. odoriphaga that are related to the adaption response to benzothiazole.
| No. | Accession ID | Description | Unique Peptide | Score | Coverage (%) | Fold change (Mean ± SD) BT/CON |
|---|---|---|---|---|---|---|
| 26 | gi|54289246 | pyrroline-5-carboxylate synthase, partial [ | 2 | 213 | 4.5 | 1.802 ± 0.147 |
| 27 | gi|284159519 | arginine kinase, partial [ | 2 | 908 | 18.1 | 1.783 ± 0.105 |
| 28 | gi|157129677 | serine hydroxymethyltransferase [ | 1 | 78 | 2.9 | 1.350 ± 0.112 |
| 29 | gi|524934116 | putative aminopeptidase [ | 2 | 172 | 4.2 | 0.524 ± 0.052 |
| 30 | gi|545916496 | putative alanine aminotransferase [ | 2 | 39 | 3.1 | 0.854 ± 0.173 |
| 31 | gi|157674465 | putative enolase [ | 2 | 1218 | 18.7 | 1.379 ± 0.096 |
| 32 | gi|545917538 | putative transaldolase, partial [ | 1 | 208 | 6.3 | 1.314 ± 0.233 |
| 33 | gi|563354904 | pyruvate kinase [ | 8 | 928 | 17 | 1.201 ± 0.130 |
| 34 | gi|405132161 | glycogen phosphorylase [ | 3 | 248 | 5.5 | 0.841 ± 0.066 |
| 35 | gi|58376929 | Glucosamine–fructose-6-phosphate aminotransferase [ | 1 | 165 | 3.7 | 0.853 ± 0.146 |
| 36 | gi|31210041 | Actin-related protein 3 [ | 4 | 284 | 12.9 | 0.749 ± 0.112 |
| 37 | gi|313482947 | putative IgE binding protein, partial [ | 1 | 318 | 23.8 | 1.569 ± 0.607 |
| 38 | gi|158300600 | Probable citrate synthase 1, mitochondrial [ | 2 | 430 | 14.8 | 1.548 ± 0.185 |
| 39 | gi|157132308 | ATP synthase beta subunit [ | 13 | 2473 | 36.9 | 1.529 ± 0.064 |
| 40 | gi|563354932 | malate dehydrogenase 1 [ | 6 | 200 | 16.9 | 1.519 ± 0.266 |
| 41 | gi|157123846 | pyruvate carboxylase [ | 9 | 233 | 7.5 | 1.310 ± 0.063 |
| 42 | gi|545919823 | putative methylmalonate semialdehyde dehydrogenase [ | 2 | 139 | 7.1 | 1.241 ± 0.135 |
| 43 | gi|108878452 | ATP synthase subunit beta vacuolar [ | 10 | 570 | 28.6 | 1.231 ± 0.083 |
| 44 | gi|56684613 | ADP ribosylation factor 79 F [ | 4 | 548 | 31.3 | 1.363 ± 0.192 |
| 45 | gi|545920491 | putative g protein [ | 5 | 234 | 13.2 | 1.355 ± 0.202 |
| 46 | gi|157136642 | ras-related protein Rab-7 [ | 3 | 130 | 15.4 | 1.184 ± 0.247 |
| 47 | gi|545918333 | putative gtpase ran/tc4/gsp1 nuclear protein [ | 5 | 328 | 28.5 | 1.156 ± 0.203 |
| 48 | gi|14906173 | putative 3′-phosphoadenosine 5′-phosphosulfate synthetase, partial [ | 1 | 44 | 4.2 | 1.592 ± 0.011 |
| 49 | gi|157131369 | Na+/K+ ATPase alpha subunit [ | 10 | 619 | 19.8 | 1.505 ± 0.226 |
| 50 | gi|545918815 | putative signal peptidase i [ | 3 | 233 | 18.9 | 0.729 ± 0.086 |
| 51 | gi|524934245 | putative microtubule associated complex [ | 3 | 110 | 13.2 | 1.262 ± 0.078 |
| 52 | gi|167874883 | 3-oxoacyl-[acyl-carrier-protein] reductase [ | 1 | 104 | 4.7 | 1.271 ± 0.318 |
| 53 | gi|545920109 | putative 60 kda heat shock protein mitochondrial [ | 1 | 239 | 7.4 | 2.184 ± 0.233 |
| 54 | gi|108868487 | Small ubiquitin-related modifier 3 [ | 1 | 208 | 12.6 | 1.994 ± 0.868 |
| 55 | gi|157122974 | prohibitin [ | 5 | 144 | 18.4 | 1.976 ± 0.065 |
| 56 | gi|545916790 | putative atp-dependent lon protease, partial [ | 5 | 129 | 5.9 | 1.425 ± 0.366 |
| 57 | gi|2738077 | heat shock protein 60 [ | 3 | 557 | 13.1 | 1.415 ± 0.105 |
| 58 | gi|157106603 | 26 S protease regulatory subunit S10b [ | 5 | 273 | 13.2 | 1.393 ± 0.136 |
| 59 | gi|89212800 | heat shock cognate 70 [ | 13 | 1725 | 39 | 1.200 ± 0.040 |
| 60 | gi|157131453 | 26 S protease regulatory subunit [ | 1 | 121 | 14.2 | 0.863 ± 0.151 |
| 61 | gi|108870669 | Rab GDP-dissociation inhibitor [ | 5 | 130 | 11.3 | 0.905 ± 0.103 |
| 62 | gi|167865143 | ebna2 binding protein P100 [ | 2 | 96 | 2.6 | 0.806 ± 0.016 |
| 63 | gi|157115283 | fatty acid synthase [ | 2 | 295 | 1.9 | 1.835 ± 0.480 |
| 64 | gi|584594454 | cytochrome P450 6FV2 [ | 1 | 114 | 4.6 | 0.748 ± 0.190 |
| 65 | gi|58396588 | 14-3-3 protein epsilon [ | 6 | 1263 | 22.7 | 0.754 ± 0.050 |
| 66 | gi|94468532 | myosin light chain [ | 3 | 107 | 19.7 | 0.822 ± 0.023 |
| 67 | gi|58378742 | Nascent polypeptide-associated complex subunit alpha [ | 3 | 358 | 18 | 1.402 ± 0.156 |
| 68 | gi|170030017 | 40 S ribosomal protein S23 [ | 2 | 338 | 15.4 | 1.681 ± 0.129 |
| 69 | gi|568255436 | hypothetical protein AND_004054 [ | 2 | 91 | 3.4 | 1.668 ± 0.091 |
| 70 | gi|329669248 | 60 S acidic ribosomal protein P1 [ | 1 | 781 | 14.5 | 1.649 ± 0.204 |
| 71 | gi|29839631 | 60 S ribosomal protein L23 [ | 4 | 538 | 31.4 | 1.584 ± 0.416 |
| 72 | gi|157674443 | 60 S acidic ribosomal protein P0-like protein [ | 1 | 635 | 22.4 | 1.535 ± 0.103 |
| 73 | gi|58392254 | 60 S ribosomal protein L12 [ | 3 | 160 | 18.2 | 1.433 ± 0.129 |
| 74 | gi|545920235 | putative elongation factor 2, partial [ | 2 | 623 | 12.8 | 1.155 ± 0.186 |
| 75 | gi|56809869 | ribosomal protein S9 [ | 6 | 189 | 23.1 | 0.697 ± 0.145 |
| 76 | gi|545920339 | putative ribosomal protein l32 [ | 3 | 436 | 16.4 | 0.739 ± 0.179 |
| 77 | gi|56199506 | ribosomal protein L27A, partial [ | 2 | 398 | 13.2 | 0.777 ± 0.046 |
| 78 | gi|401715292 | 60 s ribosomal protein L15, partial [ | 2 | 200 | 20.9 | 0.789 ± 0.287 |
| 79 | gi|157361525 | 40 S ribosomal protein S15-like protein [ | 3 | 299 | 23.1 | 0.806 ± 0.095 |
| 80 | gi|545920337 | putative 60 s acidic ribosomal protein p0 [ | 1 | 576 | 21.3 | 0.823 ± 0.240 |
| 81 | gi|269146822 | 60 s ribosomal protein L10, partial [ | 2 | 179 | 11.4 | 0.879 ± 0.091 |
| 82 | gi|157131827 | tropomyosin invertebrate [ | 1 | 176 | 25.2 | 4.289 ± 2.567 |
| 83 | gi|157127892 | paramyosin, long form [ | 1 | 146 | 3.9 | 3.158 ± 0.843 |
| 84 | gi|74920601 | ADP, ATP carrier protein 2 [ | 1 | 628 | 24.3 | 2.057 ± 0.155 |
| 85 | gi|108884438 | AAEL000311-PA [ | 1 | 174 | 1.7 | 1.474 ± 0.411 |
| 86 | gi|407379599 | gamma-glutamylcystein synthase [ | 1 | 79 | 2.4 | 1.378 ± 0.166 |
| 87 | gi|167872478 | mitochondrial processing peptidase beta subunit [ | 2 | 57 | 2.6 | 1.346 ± 0.305 |
| 88 | gi|404553129 | prophenoloxidase 6, partial [ | 2 | 60 | 7.5 | 0.695 ± 0.052 |
| 89 | gi|157109554 | titin [ | 1 | 354 | 2.4 | 0.736 ± 0.095 |
| 90 | gi|157117953 | glutamate cysteine ligase [ | 1 | 112 | 2.3 | 0.805 ± 0.250 |
| 91 | gi|158295341 | AGAP006103-PC [ | 1 | 202 | 7.5 | 0.850 ± 0.150 |
| 92 | gi|108884446 | AAEL000339-PA [ | 1 | 135 | 2.1 | 0.876 ± 0.155 |
Figure 4(A) The number of up- and down-regulated proteins of B. odoriphaga after treatment with benzothiazole for 6 and 24 h. BT: benzothiazole; CON: control. (B) Venn diagram showing the overlap between the differentially expressed proteins of B. odoriphaga at 6 and 24 h after benzothiazole treatment.
Figure 5Gene ontology (GO) enrichment analysis of the differentially expressed proteins.
The proteins are grouped into three GO terms: biological process, cellular component, and molecular function. (A) Proteins related to the action mechanism; (B) proteins related to the stress response; (C) proteins related to the adaption response.
Figure 6mRNA expression level analysis (qRT-PCR) of 6 proteins of B. odoriphaga after 6 and 24 h of benzothiazole treatment.
The relative expression level was normalized to an internal standard, ribosomal protein S3 (RPS3). Bars represent mean ± SE (n = 6). Different lower-case letters above the bars indicate significant differences at P < 0.05. TPI: triose-phosphate isomerase; V-ATPase: vacuolar ATP synthase subunit H; MyHC: myosin heavy chain; SCS: succinyl-CoA synthetase; ENO: enolase; epsilon BP: IgE binding protein.
Figure 7A summary of some of the biological pathways affected by benzothiazole in B. odoriphaga.
Green boxes represent proteins that were only down-regulated at 6 h after benzothiazole treatment, red boxes represent proteins that were only up-regulated at 24 h after benzothiazole treatment, and blue boxes indicate proteins that were down-regulated at 6 h and up-regulated at 24 h after benzothiazole treatment. EMP: glycolytic pathway; PPP: pentose phosphate pathway; TCA: tricarboxylic acid cycle; ETC: electron transfer chain; F6P: fructose 6-phosphate; F-1,6-2 P: fructose-1,6-diphosphate; TAL: putative transaldolase; S7P: sedoheptulose-7-phosphate; G3P: glyceraldehyde 3-phosphate; E4P: erythrose-4-phosphate; TPI: triose-phosphate isomerase; DHAP: dihydroxyacetone phosphate; 2-PGA: 2-phosphoglycerate; ENO: putative enolase; PEP: phosphoenolpyruvate; PK: pyruvate kinase; MAL: malate; PC: pyruvate carboxylase; OAA: oxaloacetic acid; CS: citrate synthase 1; CA: citric acid; SCS: succinyl-CoA synthetase alpha; SA: succinic acid; MDH: malate dehydrogenase; VAL: valine; MMSA: methylmalonate semialdehyde; MSDH: methylmalonate semialdehyde dehydrogenase; FA-CoA: acyl-coenzyme A; KAT: peroxisomal 3-ketoacyl-CoA thiolase; ATPase: ATP synthase beta subunit; V-ATPase: vacuolar ATP synthase subunit H; SOD: superoxide dismutase.